IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 36 filers reported holding IBERE PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,242 | -88.7% | 126,723 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $11,000 | +22.2% | 126,723 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -60.9% | 126,723 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | -66.2% | 126,723 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $68,000 | -6.8% | 126,723 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $73,000 | – | 126,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |